James I Geller MD

Pediatric Hematology & Oncology•San Diego, CA

Professor, Pediatrics, University of Cincinnati College of Medicine

Join to View Full Profile

3010 Childrens WaySan Diego, CA 92123
Phone+1 858-966-5811
Fax+1 513-636-3549

Education & Training

University of TennesseeFellowship, Pediatric Hematology/Oncology, 2000 - 2004
Westchester Medical CenterResidency, Pediatrics, 1997 - 2000
Tel Aviv University SacklerClass of 1997

Certifications & Licensure

CA State Medical License 2024 - 2027
OH State Medical License 2004 - 2027
KY State Medical License 2021 - 2025
NC State Medical License 2020 - 2022
TN State Medical License 2000 - 2006
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors Start of enrollment: 2010 Mar 01
Completed
Phase 1
Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma Start of enrollment: 2010 May 01
Withdrawn
Not Applicable
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients Start of enrollment: 2010 Aug 01
Completed
Phase 1
A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma Start of enrollment: 2011 Oct 01
Terminated
Early Phase 1
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors Start of enrollment: 2014 Sep 01
Completed
Phase 1
A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) Start of enrollment: 2019 Jan 08
ACTIVE_NOT_RECRUITING
PHASE2
TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative Start of enrollment: 2018 Aug 12
RECRUITING
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT Start of enrollment: 2020 Oct 19
RECRUITING
PHASE2
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma Start of enrollment: 2020 Nov 01
RECRUITING
PHASE2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

2 citations
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.
Daniela Perotti, Maureen J O'Sullivan, Amy L Walz, Jonathan Davick, Reem Al-Saadi
Nature Reviews. Urology. 2025-08-01
Clinical and Pathologic features of 535 Patients with Congenital Mesoblastic Nephroma: A Report from the Children's Oncology Group.
Jonathan J Davick, Lindsay A Renfro, Nicholas G Cost, Jennifer H Aldrink, James I Geller
Annals of Surgery. 2025-08-01
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives.
Kathryn S Sutton, Amy L Walz, Alissa Groenendijk, Andrew J Murphy, Luke Pater
Pediatric Blood & Cancer. 2025-08-01

Lectures

A prospective study of pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN0321.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

Experts from the University of Cincinnati Cancer Center Showcase Research at ASCO 2025May 27th, 2025
First-Ever Prospective Trial in Pediatric RCC Reports ResultsOctober 21st, 2020
Translocation Renal Cell Carcinoma (tRCC) Research InitiativeJune 24th, 2019
Join now to see all